Clinical trial
Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
NCT00064792 · Forbes Porter, M.D., NIH · Completed
Key facts
| NCT number | NCT00064792 |
|---|---|
| Title | Simvastatin Therapy in Smith-Lemli-Opitz Syndrome |
| Official title | Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome |
| Lead sponsor | Forbes Porter, M.D., NIH |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Smith-Lemli-Opitz Syndrome |
| Intervention type | Drug |
| Interventions | Simvastatin Susp., OraPlus |
| Enrollment | 23 |
| Start date | Jul 1, 2003 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Jul 14, 2003 |
| Last update posted | Jun 6, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: